ORLANDO, Fla.--(BUSINESS WIRE)--GeneLink BioSciences, Inc. (OTCBB:GNLK.OB), “the Company,” or “GeneLink”, has appointed James Antal to the Company’s Board of Directors. Mr. Antal brings decades of financial and management experience to GeneLink and will serve as Chairman of the Audit Committee.
